Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cobicistat vs Ritonavir for Darunavir Brain Permeation in HIV
NCT02503462Phase 4Terminated
- Sponsor
- University Hospital Basel
- Start
- Jul 2015
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of cobicistat in human immunodeficiency virus infection (HIV), sponsored by University Hospital Basel. Primary endpoint: Cerebrospinal fluid/plasma concentrations of darunavir at 1 month. Started Jul 2015; status: terminated.
02
Drugs
cobicistat
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02503462.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02503462.